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According to annual national mortality statistics, there has 
been a fall in the death rate for pulmonary tuberculosis, and a rise 
# 
in death rates for carcinoma of the lung and emphysema.^ The cause 
of these trends is uncertain. They may reflect alterations in the 
actual nature of these diseases, but the trends may also be due to 
improved methods of prevention and therapy, and/or changes in diagnostic 
certification. The purpose of this research was to explore the third 
of these possibilities — the role of changes in diagnostic tactics. 
The mortality data of vital statistics have traditionally been 
used for assessing rates of disease, because the data are epidemiologically 
complete; a death certificate is prepared whenever someone dies. On 
the other hand, the use of death certificates as a source of data 
creates significant questions about the reliability of the data. The 
contents of the certificates will be affected by the variability of 
individual clinicians, by variations in nomenclature and coding, and 
2 
by changes in diagnostic standards. Although individual clinicians 
may apply the same diagnostic standards differently, a change in the 
standards themselves can affect the rates of disease more profoundly 
than any vicissitudes of the people who use the standards. 
To analyze these events, this investigation was concerned with 
the diagnostic criteria and rates of occurrence of three major pulmonary 
■ 
2 
diseases — tuberculosis, cancer, and emphysema — during a span of 
40 years at the New Haven Hospital. 
PROBLEMS IN DIAGNOSTIC CRITERIA 
A clinician’s diagnosis is based (1) on his ability to recognize 
and accurately identify clinical signs and symptoms, (2) on para- 
clinical aids — including x-ray and laboratory data — available at 
the time of diagnosis, and (3) on the standards used for interpretation 
of this information. Although a physician may precisely identify the 
clinical phenomena, the latter factors may alter his accuracy in 
diagnosis. The sections that follow are devoted to the refinements in 
paraclinical aids and the changes in diagnostic standards that have 
occurred for the three pulmonary diseases under survey. 
1. Tuberculosis 
Tuberculosis provides a classic example of change in diagnostic 
standards. In 1920, the official Diagnostic Standards of the National 
Tuberculosis Association contained a section itemizing "minimum 
standards" for diagnosis of pulmonary tuberculosis in adults with 
negative sputum: 
1. When constitutional signs and symptoms and definite 
past history are absent or nearly so, there should be 
demanded definite signs in the lungs, including persistent 
rales at one or both apices. By "persistent" it is meant 
that the rales must be present after cough at two or more 
examinations, the patient having been under observation 
at least one month. 
2. In the presence of constitutional signs and symptoms 
such as loss of weight and strength, etc.,...there should 
be demanded some abnormality in the lungs, but not 
necessarily rales. X-ray evidence of apical infiltration 
may be of importance. 
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3. Usually a process at the apices should be considered 
tuberculous and a process at the base to be non- 
tuberculous until the contrary is proved, excepting 
when a clear history of pleurisy is present. 
4. A hemorrhage [defined elsewhere as "expectorated 
blood, with or without sputum...when of one or two 
teaspoonsful"] is evidence of active pulmonary 
tuberculosis until the contrary is proved. [Publication 
notes that "blood streaks, blood spots, etc., may or 
may not mean tuberculosis."] 
5. One should consider a typical pleurisy with 
effusion as presumptive evidence of tuberculosis.... 
Later editions of this publication illustrate the increasing specificity 
of evidence demanded for diagnosis of this disease. In 1940: 
If sputa and gastric washings are carefully and 
repeatedly examined,...negative results are of 
distinct diagnostic value. It can be safely said, 
that a patient with a demonstrable parenchymal 
infiltration in the lung that is apparently active, 
in whom tubercle bacilli cannot be demonstrated, 
probably has a non-tuberculous lesion.4 
In 1961: 
The demonstration of tubercle bacilli in clinical 
specimens is the one essential criterion in the 
definite diagnosis of active tuberculosis.5 
These different statements show a change in the demands for 
demonstration of the tubercle bacillus. Moreover, the diagnostic 
criteria of 1920 would have permitted a designation of tuberculosis 
to be given to many respiratory diseases that would receive other 
diagnoses today. For example, hemoptysis, i.e., "hemorrhage", is no 
longer considered to be presumptive evidence of active pulmonary 
tuberculosis, but may be a symptom of many other diseases, including 
bronchogenic carcinoma. The more extensive modern availability and 
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use of radiographic techniques, cytologic and histologic evaluation, 
and other laboratory methods have helped traverse the gap between the 
clinical picture and the morphologic nature of disease, and thereby 
increase accuracy in diagnosis. 
_2. Carcinoma of the Lung 
Ever since 1887, when Hampeln reported establishing the diagnosis 
of primary carcinoma of the lung in a patient five months before the 
diagnosis was verified post-mortem, the importance of microscopic 
diagnosis of the disease has been frequently investigated and verified. 
In 1935, Dudgeon and Wrigley, using a wet film method, demonstrated 
malignant cells in the sputa of patients with carcinoma of the lung or 
8 9 
larynx. In 1946, Papanicolaou applied his smear technique to sputa, 
and the value of cytodiagnosis was verified soon after in controlled 
_ ,. 10 
studies. 
Cytologic and roentgenologic methods complement each other in 
the diagnosis of lung cancer. A carcinoma less than one centimeter 
in diameter cannot be visualized with standard x-ray methods. -^Although 
"...there is no characteristic roentgenographic picture of carcinoma 
of the lung which clearly distinguishes it invariably from other 
12 
pulmonary lesions," radiography often discovers peripheral clinically 
silent lesions and, in general, provides precise localization of 
13 
lesions. Cytology is of particular value in diagnosis of centrally 
14 
located lesions, which are often hidden on x-ray by hilar shadows. 
Histologic methods also aid in accurate diagnosis of pulmonary 
6, 7 
disease. Diagnostic lung puncture was first reported by Leyden in 
1883, after he used this technique to obtain bacteriologic diagnosis 
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from a pneumonic lung.^"* Martin and Ellis later applied the procedure 
to diagnosis of neoplastic disease.^ Since the development of 
alternative methods of obtaining histologic specimens, such as 
bronchoscopy and scalene node biopsy,"^ needle biopsy is much less 
frequently used, but is still advocated for "undiagnosed pleural 
effusions and peripheral bronchogenic tumors fixed to or invading the 
chest wall."^ 
Medical science has thus progressed to the point where many 
procedures are available to help determine the presence of lung cancer. 
But there is at present no one procedure which can be satisfactorily 
applied to all cases of suspected carcinoma of the lung. "A complete 
study may include bronchoscopy, bronchography, exfoliative Cytology, 
scalene node biopsy, or early exploratory thoracotomy if doubt persists 
19 
as to the diagnosis." 
3. Emphysema 
Unlike demonstration of the tubercle bacillus in tuberculosis 
or the malignant cell in carcinoma of the lung, no single criterion 
is available to assure accurate clinical diagnosis for emphysema. 
20 
Emphysema itself is defined in morphologic terms yet, in most cases, 
the clinician must rely on radiographic examination and pulmonary 
function tests as guides to the presence of this morphologic entity. 
The ambiguity of the clinical diagnosis of emphysema is 
illustrated by differing viewpoints about which radiologic findings — 
including depression and flattening of diaphragms, blunting of 
costophrenic angles, irregular radiolucency of lung fields, enlarged 




correlate with the anatomic findings. According to one official 
statement on diagnostic standards, "except when bullae are present, 
roentgenologic examination cannot reliably distinguish between 
20 
pulmonary emphysema and overinflation due to other causes." Clinical 
manifestations of emphysema vary, and some patients may be asymptomatic 
with no abnormal physical signs, yet have morphologic evidence of 
20 
emphysema upon examination of their lungs. 
In general, a reasonably good correlation has been found between 
pulmonary structure and function, and pulmonary function tests have 
24 
been useful for diagnostic purposes. There is no single function 
which definitively determines the presence of emphysema; however, 
certain ventilatory measurements, including forced expiratory volume 
per unit of time (usually FEV^ sec.), forced expiratory flow (^12^200-1200’ 
previously called maximum expiratory flow rate, MEFR), and pulmonary 
nitrogen washout curves correlate best with the presence of,disease. 
Measurements of vital capacity and diffusing capacity are not as 
25—28 
reliable. Although the presence of airway obstruction generally 
correlates well with the presence of emphysema at necropsy, and although 
emphysema is usually associated with reduction in expiratory air flow, 
26 27 29 
airway obstruction may exist without emphysema. ’ ’ Thus, 
2 
emphysema today remains a presumptive and recently popularized clinical 
diagnosis, but it "...should only be applied to those cases in which, 
in the observer's opinion, the defined morbid anatomical changes of 
30 
emphysema can confidently be asserted to be present." 
AAA 
From these statements, one can anticipate that diagnostic 
standards for tuberculosis, carcinoma of the lung, and emphysema 
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would be different today from what they were at various times in the 
past. This study seeks to determine how different these standards 
have been, and how these differences have been applied in the 
evaluation of patients. 

8 
MATERIALS AND METHODS 
A. CLINICAL MATERIAL 
The study initially included all patients discharged from New 
Haven Hospital, during 1921, 1941, and 1961, with the diagnosis of 
pulmonary tuberculosis, carcinoma of the lung, or emphysema. The year 
1921 was chosen for survey because it was the first year for which a 
cross-index system based on discharge diagnoses was established at 
the hospital; 1941 was selected because it occurred 20 years later 
while still preceding the advent of antibiotic therapy; 1961 was 
chosen because it marked the end of another twenty-year period, and 
because antibiotics were then available. 
A search through the cross-index files of the hospital 
revealed 648 patients discharged during the survey years with the 
appropriate diagnoses. The details of the solicited and acquired 
case records are presented in Table 1. 
Of these 648 cases, four records from 1921, 11 records from 
1941, and 21 records from 1961 could not be located by the record room 
staff despite repeated searches between June 1967 and April 1968. 
Other case records were, after review, excluded from further analysis 
for the following reasons: 
1. Several charts had apparently been cross-indexed incorrectly 
in the diagnostic file, and contained either no mention of hospital 
discharge during the survey years, or the patient was discharged after 
hospital admission for an illness unrelated to those under survey. One 
case from 1921, 43 cases from 1941, and 14 cases from 1961 were excluded 
on this basis. 
2. Several patients with tuberculosis or carcinoma were 

9 
excluded because of uncertain diagnoses in which the disease was 
specified only as probable or suspected: the cases of questionable 
tuberculosis were 12 in 1921, four in 1941, and six in 1961; the 
cases of questionable cancer were two in 1941 and seven in 1961. 
3. Several cases of inappropriate forms of emphysema were 
excluded. These were: one case of subcutaneous emphysema following 
trauma, 1921; one case of compensatory emphysema secondary to 
obstructive atelectasis, 1961; and two cases of "emphysema" in 
newborns, 1961. 
The remaining 519 cases defined the study population. 
JJ. EXTRACTION AND CODING 
In each case record, the patient’s entire clinical course was 
thoroughly reviewed. The review included all data obtained before 
and during the patient's hospitalization for the year under survey. 
The available diagnostic evidence was extracted on a special form 
according to a set of criteria established for the extraction 
(Appendix 1). An open-type form was used, in order to avoid omission 
of any clinical or ancillary paraclinical diagnostic evidence. The 
form used for the extraction of data is shown in Appendix 2. Critical 
diagnostic evidence obtained at any time before the survey admission, 
or after it but during the same year, was included and its source 
specifically identified. 
After all the records were extracted, criteria were established 
(Appendix 3) for coding the extracted data onto eighty-column Hollerith 
coding sheets. All the extractions and coding were done and checked 




the code, and the punched cards were then verified. The punching and 
verifying were done by two different people. A print-out of the coded 
data was then spot-checked by the author. After these verifications, 
the data were analyzed with an IBM Card Sorting Machine, according to 
procedures described in the next section. 
In addition to analysis of data available to establish diagnosis 
of these three pulmonary diseases, a tabulation was made, for each 
index year, of the total number of hospital admissions and the number 
of admissions of other pulmonary diseases that might present a clinical 
picture similar to those of the three diseases under study. The 
latter included all the cases cited in the cross-index file of discharge 
diagnoses for a variety of pulmonary diseases (listed in Table 4). 
C. METHOD OF ANALYSIS 
_1. Consideration of Supportive Evidence 
Each diagnosed disease was analyzed separately for each survey 
year. Certain data were regarded as supportive evidence of diagnosis. 
When these findings were present, the evidence was marked "positive". 
The criteria for positive supportive evidence in each disease were as 
follows: 
Tuberculosis; 
a. Clinical evidence - presence of symptoms and/or signs. 
(1) Symptoms - included pulmonic or infectious symptoms, and/or 
systemic symptoms. (Pulmonic or infectious symptoms are 
those indicated in coding criteria columns 16-19, 21-23, 
Appendix 3. Systemic symptoms are anorexia, weakness 
and/or fatigability, significant malaise, and weight loss 
_ 
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of ten pounds or more.) 
(2) Signs - included intrapulmonic and/or extrapulmonic 
signs (see coding criteria columns 26-33, Appendix 3). 
b. Demonstration of tubercle bacillus - in sputum, bronchial 
secretions, gastric washings, pleural fluid, swab of lesion 
or biopsy specimen or histologic specimen itself. 
c. Positive chest x-ray - included identification of lesion 
and/or pleural effusion. 
d. Positive skin test. 
Primary Carcinoma of the Lung: 
a. Clinical evidence - presence of appropriate symptoms and/or 
signs, as for tuberculosis. 
b. Positive histologic evidence - included bronchoscopic biopsy, 
lymph node (supraclavicular, axillary, paratracheal, or 
cervical), aspiration biopsy of mediastinum, needle biopsy of 
lung, or biopsy of lung or pericardium. 
c. Positive cytologic evidence - included sputum pap smear, 
pleural fluid or bronchoscopic cytology. 
d. Positive chest x-ray - included identification of lesion 
and/or pleural effusion. 
Emphysema: 
a. Clinical evidence - presence of appropriate symptoms and/or 
extrapulmonic signs. 
(1) Symptoms - as for tuberculosis. 
(2) Extrapulmonic signs - included clubbing of nails, use 
of accessory muscles of respiration, cyanosis, or 
■ 
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increased A-P diameter of the chest. 
b. Positive chest x-ray - included x-ray report with statement of 
"emphysema" or "findings consistent with emphysema" or "grossly 
emphysematous configuration of the lung fields" or "probable 
emphysema" or mention of presence of bullae. 
c. Positive pulmonary function tests - at least "moderate" 
dysfunction, as indicated with standardized qualitative 
description found in all cases in which complete pulmonary 
function studies were done. 
2_. Criteria for "Justified Diagnoses" 
After analysis of the different supportive evidence available 
for diagnosis of these diseases, criteria were established for a 
"justified diagnosis". A diagnosis was considered to be "justified" 
whenever any one of the conditions cited below was fulfilled: 
Pulmonary Tuberculosis: 
a. Positive x-ray and demonstration of tubercle bacillus; or 
b. Demonstration of tubercle bacillus and positive skin test; or 
c. Autopsy: pulmonary tuberculosis — if patient died during 
survey admission. 
Primary Carcinoma of the Lung: 
a. Positive x-ray and either histologic or cytologic evidence, 
regardless of site; or 
b. Negative x-ray and primary site evidence (histologic or cytologic). 
Note: Primary site = sputum cytology, bronchoscopic biopsy 





a. Positive x-ray; or 
b. Positive pulmonary function tests. 
Although the criteria cited for a diagnosis of pulmonary 
tuberculosis refer to active tuberculosis, there was no clear indication 
in most records whether the diagnosis of "pulmonary tuberculosis" 
referred to active or inactive disease. Those cases considered to 
have "unjustified diagnoses" according to the above criteria were, 
therefore, divided into two groups: those managed as if they had 
active tuberculosis, and those who did not receive antituberculosis 
therapy. For these purposes, "antituberculosis therapy" or "active 
management" consisted of any one of the following procedures: 
antituberculosis drug therapy; patient sent to sanatorium or sanatorium 
advised; recommendation of prolonged bed rest at home or outdoor 
employment in the country. Patients who had no "active management" 
were further subdivided into cases in which the diagnosis of tuberculosis 
was used to explain the clinical picture, and those in which it was not. 
If the patient was not treated as though he had active tuberculosis, 
and if this diagnosis was not used to explain the clinical picture, his 
diagnosis was removed from the final "unjustified" group. The final 
group of "unjustified diagnoses" of tuberculosis thus included those 
cases of the original "unjustified" group who received antituberculosis 
treatment or in whom the diagnosis of tuberculosis was used to explain 




A. TYPES _0F AVAILABLE EVIDENCE 
The different evidence available at time of diagnosis of 
tuberculosis, primary carcinoma of the lung, and emphysema is 
summarized in Table 2. 
Of particular note is the frequency with which clinical evidence 
alone was used to establish diagnosis of tuberculosis and emphysema 
in 1921, and the increasing use of paraclinical evidence thereafter. 
In 1921, 40% of tuberculosis diagnoses were made on the basis of 
clinical evidence alone, as compared with only 2% and 6% of cases in 
1941 and 1961. Although diagnosis of emphysema in a purely clinical 
manner also declined from 86% of cases in 1921 to 48% in 1941, 36% 
of diagnoses were still being made on this basis in 1961. In contrast, 
carcinoma of the lung was never diagnosed only with purely clinical 
evidence during these years. 
The data also indicate an increased use of chest x-ray for 
diagnosis of tuberculosis and emphysema since 1921. Although 44% of 
diagnosed cases of tuberculosis in 1921 apparently had no chest x-ray 
taken, roentgenographic examination was done in nearly all cases in 
the more recent years, and the percentage of patients with positive 
x-rays also increased sharply. Diagnosis of emphysema without the 
aid of x-ray also decreased after 1921, although less dramatically 
than for tuberculosis. The rate of positive x-rays in cases diagnosed 
as emphysema also rose, from 14% in 1921 to 52% in 1941, but fell to 
41% in 1961. 
Carcinoma of the lung was nearly always diagnosed after x-ray, 
which was usually positive, during all three years. Cytologic and 
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histologic evidence have been used increasingly for this diagnosis 
since 1941. Forty-six per cent of cases during that year were 
diagnosed from positive x-ray, without supplementary histologic or 
cytologic verification; only 7% of cases were thus diagnosed in 1961. 
In diagnosis of tuberculosis, demonstration of the tubercle 
bacillus increased, although to only 53% of cases in 1961. The 
incidence of administration of skin tests did not rise greatly, and 
the rate of positive skin tests rose only 7% to 23%. 
_B. JUSTIFIED DIAGNOSES 
According to the criteria given previously for justified 
diagnosis of tuberculosis, carcinoma of the lung, and emphysema, 
accuracy of their diagnosis has increased during the survey period 
(Table 3). The frequency with which justified diagnoses of pulmonary 
tuberculosis were made rose steadily, from 24% of cases in 1921 to 
50% in 1941 and 77% in 1961. Excluding the single case of carcinoma 
of the lung in 1921, which was apparently correctly diagnosed, 
accuracy in diagnosis of that disease has also increased, from 64% 
in 1941 to 94% in 1961. In contrast, although the percentage of 
justified diagnoses of emphysema rose from 14% in 1921 to 52% in 1941, 
accuracy improved only slightly to 57% in 1961. Indeed, if more 
stringent criteria are applied, i.e., bullae seen on x-ray and/or at 
least moderate expiratory resistance, only 16% of diagnoses in 1961 
were justified. 
C. OTHER PULMONARY DISEASES 
Tabulation of the number of admissions to the same hospital 
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during 1921, 1941, and 1961 for diagnosed diseases that could present 
overlapping clinical pictures is given in Table 4. In Table 5, these 
numbers are divided by the total number of hospital admissions to 
provide the occurrence rates of hospitalization with respiratory 
illnesses during each year. Of interest is the decreasing annual 
incidence of tuberculosis, bronchitis and bronchiectasis, lung abscess 
and empyema, and pleurisy, as compared with the rise in occurrence 
of carcinoma of the lung, asthma, congestive heart failure and 
pulmonary edema, and Hodgkin's disease and lymphosarcoma. The 
diagnostic frequency of emphysema was highest in 1921, with a fall in 
1941, and a later rise in 1961. This change in the "hospitalization" 
rate of emphysema is in marked contrast to its rising annual "mortality" 
rate, as noted in the data of the United States Vital Statistics 
_ 1, 2 
reports. 
Of particular note is the sharp decline after 1921 in total 
incidence of hospitalizations with any form of respiratory illness. 
The rate in 1921 was 1697 per 10,000 admissions; the rate of 570 in 




These results demonstrate, according to current standards, that 
accuracy in diagnosis of pulmonary tuberculosis, primary carcinoma of 
the lung, and emphysema has increased significantly since 1921. 
As exemplified by tuberculosis, changes in diagnostic standards 
have been a key factor in more accurate diagnosis. Demonstration of 
the tubercle bacillus is crucial for diagnosis of active disease today, 
but was not in 1921, when clinical presumptive evidence alone was 
considered sufficient for diagnosis. The same signs and symptoms that 
are now known to indicate the presence of one or more of several other 
diseases, could thus be considered diagnostic of tuberculosis in 1921. 
Although a history of contact with active cases of tuberculosis was not 
analyzed as a variable in this study, it seems likely that such an 
epidemiologic history was an important factor at that time. 
Advances in technology have helped produce more accurate diagnosis 
and diagnostic standards. Increased reliance on cytology and histology 
have reduced the instances in which carcinoma of the lung is diagnosed 
by x-ray and clinical evidence alone. Use of multiple diagnostic 
procedures, especially in cancer diagnosis, has compensated for the 
relative insensitivity of an individual biopsy and/or cytology specimen. 
The literature indicates the variability and unreliability of 
clinical evidence and x-ray — except when bullae are identified — as 
indicators of the presence of emphysema. Pulmonary function tests are 
recognized as a valuable adjunct in correlating pulmonary structure 
and function in this disease. Yet by 1961, such tests were applied to 
only 20% of suspected cases. These data exemplify the way in which the 
incidence of diseases can "fluctuate with their fashions in clinical 
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diagnostic popularity." Although official diagnostic standards have 
been established to provide fairly good correlation between the 
presumptive clinical diagnosis of emphysema and its morphologic 
existence, many clinicians utilize their own separate diagnostic 
standards, which rely on clinical evidence alone. 
$ 
This study is limited by its approach. It considers only cases 
of diagnosed tuberculosis, lung cancer, and emphysema. It does not 
include all missed cases of these diseases. The one reported case in 
1921 of carcinoma of the lung would probably be considered the same 
disease today. It seems likely, however, that other diagnoses of this 
disease were missed during that year, perhaps because the patients 
were asymptomatic, or perhaps because they presented with clinical 
pictures similar to other respiratory illnesses and were then misdiagnosed. 
One can only guess as to what the many "unjustified" diagnoses 
of tuberculosis, carcinoma of the lung, and emphysema in the past would 
be called today. It is important to realize that the changing 
incidence rates of hospital diagnoses shown in Table 5 are distorted 
to the extent that hospitalizations during these different years were 
the result of varied iatrotropic stimuli. Thus, what brought people 
to the hospital in 1921 may not have caused them to be hospitalized 
in 1941 and 1961. Having noted these qualifications, one can at best 
speculate as to the true nature of misdiagnosed illnesses, and wonder 
only at such examples as the increasing annual incidence of asthma, 
congestive heart failure and pulmonary edema, and the decrease of 
pleurisy. The marked decline after 1921 in incidence of hospitalization 
for the cited respiratory diseases cannot be attributed to the advent 
of antibiotics; antibiotics were not yet available in 1941. The 
' 
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decline may represent changes in diagnostic standards, altered hospital 
admission policies, or both. 
This study is not intended to condemn past diagnosis with the 
aid of a knowledgeable "retrospectoscope". Clinicians of the past did 
not have the paraclinical tests now available to help convert bedside 
evidence into accurate diagnosis. Indeed, forty years from today, 
when there may exist a more satisfactory way of diagnosing emphysema, 
a reviewer of the 1968 diagnoses of this disease will probably pity the 
poor clinician who had to rely on presumptive clinical evidence for 
diagnosis. 
This study emphasizes the dangers of comparing the incidence 
rates of chronic pulmonary disease — in particular tuberculosis, 
carcinoma of the lung, and emphysema — diagnosed at different times 
and with different diagnostic standards. The results suggest that a 
substantial part of the reported change in incidence of these diseases 





This study explores the effects of changing criteria on the 
diagnosis of pulmonary tuberculosis, carcinoma of the lung, and 
emphysema during a span of 40 years at the New Haven Hospital. 
The data available to establish diagnosis were analyzed for 
519 cases discharged with one or more of these diagnoses in 1921, 
1941, or 1961. The results indicate decreasing reliancfe on clinical 
signs and symptoms alone to establish diagnosis of tuberculosis and 
emphysema. The diagnostic evidence was exclusively clinical for 
tuberculosis in 40% of cases in 1921, in 2% in 1941, and in 6% in 1961; 
for emphysema, in 86% of cases in 1921, 48% in 1941, and 36% in 1961. 
In contrast, cancer of the lung was usually diagnosed after positive 
x-ray during all three survey years; however, 46% of diagnoses in 1941 were 
made without supplementary histologic or cytologic verification, whereas 
only 7% of cases were thus diagnosed in 1961. For tuberculosis, the 
tubercle bacillus was demonstrated with increasing frequency during the 
survey period, rising from 16% in 1921 to 53% of cases in 1961. 
After analysis of the different supportive evidence available 
for diagnosis of these diseases, criteria were established for a 
"justified diagnosis". According to these criteria, accuracy in 
diagnosis has increased: for tuberculosis, from 24% of cases in 1921 
to 50% in 1941, and 77% in 1961; for carcinoma of the lung — excluding 
the single "justified" case in 1921 — 64% in 1941, and 94% in 1961; 
for emphysema, 14% in 1921, 52% in 1941, and 57% in 1961. 
In order to obtain clues as to the true nature of these 
"unjustified diagnoses" of tuberculosis, cancer of the lung, and emphysema, 
tabulation was made of the total hospitalizations and the number of 
A 
21 
admissions to the same hospital with diagnosed illnesses that could 
present a clinical picture similar to those of the diseases under study. 
o , _ c 
The results of this study thus suggest that a substantial 
part of the reported change in incidence of pulmonary tuberculosis, 
carcinoma of the lung, and emphysema may be a consequence of change 






No. of cases listed 65 
No. of cases missing 3 
No. of cases excluded 12 
no. of cases studied 50 
CARCINOMA OF THE LUNG 
No. of cases listed 1 
No. of cases missing 0 
No. of cases excluded 0 









Ca) 24(22=1° Ca) 83(68=1° 
(2=2° Ca)t (15=2° 
PULMONARY EMPHYSEMA 
No. of cases listed 17 36 125 
No. of cases missing 1 0 6 
No. of cases excluded 2 10 11 
No. of cases studied 14 26 108 
CO-MORBIDITY* 
Tuberculosis & Emphysema 0 1 7 
Tuberculosis & Carcinoma 0 1(2° Ca)t 1(1° 
Emphysema & Carcinoma 0 0 2(1° 
TOTAL CASES STUDIED 
Tuberculosis 50 124 87 
Carcinoma of the lung 1 25 86 
Emphysema 14 27 117 
Total 65 174tt ff 290tt 
*A11 cases listed were studied. 
tAfter record was obtained, these cases were discovered to have secondary 
(metastatic) lung cancer and were excluded from further analysis. 






DIFFERENT EVIDENCE USED TO DIAGNOSE 
TUBERCULOSIS, CARCINOMA, AND EMPHYSEMA 
TUBERCULOSIS 
Total Cases 
Clinical Evidence Only 
AFB Shown During Life 
Positive Chest X-ray 
Chest X-ray Not Done 
Positive Skin Test 
Skin Test Not Done 
PRIMARY LUNG CANCER 
Total Cases 
Clinical Evidence Only 
Positive Chest X-ray 
Chest X-ray Not Done 
Histologic Evidence 
Cytologic Evidence 
Positive X-ray; No Histologic 
or Cytologic Evidence 
EMPHYSEMA 
Total Cases 
Clinical Evidence Only 
Positive Chest X-ray 
Chest X-ray Not Done 
Bullae on X-ray 
Abnormal Pulmonary Fen. Tests 
Pulm. Fen. Not Tested 
Bullae + Abnormal Pulm. Fen. 
Bullae + Significant Expiratory 
Resistance 
1921 1941 1961 
50 124 87 
20 (40%) 3 (2%) 5 (6%) 
8 (16%) 52 (42%) 46 (53%) 
25 (50%) 118 (95%) 74 (85%) 
22 (44%) 1 (1%) 3 (3%) 
8 (16%) 22 (18%) 20 (23%) 
42 (84%) 94 (76%) 64 (74%) 
1 22 71 
0 (0%) 0 (0%) 0 (0%) 
1 (100%) 21 (95%) 63 (89%) 
0 (0%) 0 (0%) 2 (3%) 
1 (100%) 11 (50%) 52 (73%) 
0 (0%) 2 (9%) 30 (42%) 
0 (0%) 10 (46%) 5 (7%) 
14 27 117 
12 (86%) 13 (48%) 42 (36%) 
2 (14%) 14 (52%) 48 (41%) 
5 (36%) 4 (15%) 7 (6%) 
0 (0%) 0 (0%) 6 (5%) 
0 (0%) 0 (0%) 34 (29%) 
14 (100%) 27 (100%) 94 (80%) 
0 (0%) 0 (0%) 38 (32%) 
0 (0%) 0 (0%) 19 (16%) 

TABLE 3 
OCCURRENCE RATES OF "JUSTIFIED1' DIAGNOSES 






















Numerators = number 
Denominators = total 
of cases 
number 
with "justified" diagnoses, 
of cases with indicated diagnosis. 
*According to modified diagnostic criteria cited in text. 

TABLE 4 
NUMBER OF HOSPITALIZATIONS WITH VARIOUS 
RESPIRATORY ILLNESSES AT NEW HAVEN HOSPITAL 
DISEASE GROUP 
1921 1941 1961 
Pneumonia, Aspiration Pneumonia, 
Bronchopneumonia 
9 246 548 
Bronchitis, Bronchiectasis 14 169 203 




1 2 1 
Pulmonary Infarction, Pulmonary 
Embolism 
16 41 66 
Lung Abscess, Empyema 18 62 20 
Pleurisy (Nontuberculous) 12 25 25 
Pneumothorax 6 10 35 
As thma 0 0 99 
Hodgkin's Disease, Lymphosarcoma 0 5 41 
Pneumoconioses, Farmer's Lung 0 10 11 
Pulmonary Sarcoidosis 0 0 1 
Congestive Heart Failure, 
Pulmonary Edema * 
1 21 154 
Pulmonary Tuberculosis 50 124 87 
Carcinoma of Lung (All Types) 1 25 86 
Pulmonary Emphysema 14 27 117 

TABLE 5 
INCIDENCE RATES OF HOSPITALIZATION WITH 
VARIOUS RESPIRATORY ILLNESSES AT NEW HAVEN HOSPITAL 
1921 1941 1961 
TOTAL NUMBER OF HOSPITALIZATIONS 836 13,106 28,439 
DISEASE GROUP (Incidence/lO^ Adm.): 
RATES 
Pneumonia, Aspiration Pneumonia, 
Bronchopneumonia 
108 188 193 
Bronchitis, Bronchiectasis 167 12 9 72 




12 2 <1 
Pulmonary Infarction, Pulmonary 
Embolism 
191 31 23 
Lung Abscess, Empyema 215 47 7 
Pleurisy (Nontuberculous) 144 19 9 
Pneumothorax 72 8 12 
As thma 0 0 35 
Hodgkin's Disease, Lymphosarcoma 0 4 14 
Pneumoconioses, Farmer's Lung 0 8 4 
Pulmonary Sarcoidosis 0 0 <1 
Congestive Heart Failure, 
Pulmonary Edema 
12 16 54 
Pulmonary Tuberculosis 597 95 31 
Carcinoma of Lung (All Types) 12 19 30 
Pulmonary Emphysema 167 20 41 
TOTAL INCIDENCE RATES OF ABOVE 
RESPIRATORY ILLNESSES 
1697 570 527 

APPENDIX 1 
Criteria for Extraction: Diagnostic Evidence Study 
Age: as recorded in admission note, or by calculation from Date of Birth 
& Zero Time. 
Race: as recorded in diagnostic sheet or adm. note. 
Year: Index year. If Zero Time occurred in previous year, put that year 
in parenthesis. Zero Time = date of first discharge at which the 
target diagnosis was recorded. 
Dx: TBC, EMPH, or CA — or combinations. Specify whether 1° Ca lung or 
2° Ca. 
Iatrotropic Stimulus: Record only if it is not one of the symptoms. 
Use "—3>- " to point to the symptom(s), cited in the next section, 
that acted as iatrotropic stimulus. 
Symptoms: Respiratory or allied complaints cited in "Present Illness" 
or in progress notes. "Allied complaints" = fever, weight loss, 
sweats, etc. Severity of disease = total effect on patient’s 
ability to work or to perform acts of daily life. 
Signs: Omit pulmonary findings except location. Record location as 
RUL (R. upper lobe), RLFP (R. lower field, posteriorly) or other 
appropriate abbreviations. [Keep track of abbreviations.] Clubbing, 
fA-P diam., use of access, muscles: Record only if unequivocal. 
Other: Includes cyanosis, etc. 
Chest X-Ray: Location of lesion: use lobes or fields (e.g., RUL, LLF), 
or other designations as appropriate. Cavity, abscess, empyema, 
effusion: Use if equivocal (otherwise no symbol), and cite location. 
Evidence for TBC 
Skin Test: Circle the preparation (Tbcln or PPD) that was used; record 
strength; indicate results as positive ( + ), equivocal ( @ ), 
negative ( - ), or not done ( ND ). Sputum smear and sputum cultufe 
for TBC: record only the result, using symbols as above. Gastric 
washing: is usually injected in a guinea pig. Note if done other¬ 
wise, or if some other substance was injected in the guinea pig. 
Other Skin Tests: Record only the reaction as ij , - , , or ND. 
Note appropriately if some other test (e.g., complement fixation) 
was used. 
Sputum Pap Smear: Record number positive per number done. E.G., 2/6 
means 2 pos. and A neg. tests. Use a middle section for equivocals, 
e.g., 0/4/6 means 0 pos., A equivocal and 2 neg. tests. 
- 
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Bronchoscopy: Record as ND, Neg., or location of observed lesion. 
(Don't describe lesion unless it was a mass; if so, record "mass"). 
Enter results, if available, of Bronchial washings (for TBC or CA) 
or of biopsy. 
Pleural Fluid: When available (otherwise "NA") ; describe as bloody, 
serosanguinous, amber, or purulent, according to gross description. 
Record any pertinent smears, cytologic tests, or cultures. 
"Pertinent" - in regard to TBC or CA. 
Biopsy: Record results of biopsy of any structure other than bronchus. 
If not pos. for TBC, EMPH, or CA, record as @ 
Resp. Fen. Tests: Record degree (slight, moderate, severe) of respiratory 
impairment for each of categories cited in chart: 
Pulmonary distention 
Pulmonary restriction 
Impaired dynamic function 





Disposition: Record anti-tuberculous Rx by name (not dose), e.g.. Strep. 
& INH. If pt. had surgery, note what was done (e.g., R. upper 
lobectomy) and the diagnostic finding in the removed specimen 
(e.g., TBC granuloma & pos. AFB smear). 

APPENDIX 2 
DIAGNOSTIC EVIDENCE STUDY 
Name Age Sex Race Year Dx 
Iatro. Stim. : 
Symptoms: Chest X-ray 





Evidence for TBC 










Sputum Pap Smear: 







Resp. Fen. Tests: 




(For Hollerith Card) 
(1), (2), (3): CODING NUMBER 
(4), (5): AGE 
Years as of last birthday 
00 = unknown 
01 = one year or less 
(6) : SEX AND RACE 
1: male, white 
2: male, Negro 
3: male, race unknown or other 
4: female, white 
5: female, Negro 
6: female, race unknown 
(7) : DIAGNOSIS 
Tuberculosis - 1 
Emphysema - 2 
Carcinoma Lung - 4 
(For combinations of above, add numbers.) 




(9) : ZERO TIME 
0: same as survey year 
1: 0-1 year preceding survey year 
2: >1 year and <5 years preceding 
3: >5 years and <10 years preceding 
4: >10 years preceding 
5: "chronic" 
6: unknown 
(10) : SOURCE OF DIAGNOSTIC EVIDENCE CITED 
0: survey year admission only (or <2 weeks preceding admission) 
1: survey year adm. + zero time 
2: survey year + within one year previous (hosp. or clinic) 
3: survey year + time between then and zero time 
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no mention of change in status 
before * event (* event = symptoms 
tbc., emph., or Ca.) 
before * event but continued smoking 
after onset of * event 
after * event but continued smoking ‘ 
in past; when? 
(12): customary cigarettes (most common mode prior to * event) 
0: none or rare 
1: <1/2 pack/day 






(13): other tobacco habits 
no mention of other habits - 0 
pipes - 1 
cigars - 2 
snuff or chewed - 4 
uses tobacco but category unknown - 9 
(14): COMPLAINANT STATUS 
0: not applicable; autopsy discovery 
1: Complaints due to pulm. symptoms. 
2: Pulm. symptoms; complaints due to other situation. 
3: Pulm. symptoms; complaints due to these + other situation. 
4: No pulm. symptoms; complaints due to other situation. 
5: Complaints of ? attribution. (Pt. may or may not have 
other symptoms attributed to lung.) 
6: Symptoms of ? attribution or ? existence; complaints due 
to other situation. 
7: Complaints not clearly determined. 
(15): IATROTROPIC STIMULUS 
0: not applicable (0, 1, 7 above) 
1: Sx. of other disease; probably unrelated to T.E.C. 
(tuberculosis, emphysema or carcinoma) 
2: Sx. of other disease; relation to T.E.C. unclear. 
3: Sx. of other disease; probably related to T.E.C. 
4: regular follow-up of a chest disease 
5: abnormal finding on chest x-ray 
■= 
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SYMPTOMS 
(16) : DOE - 1 
PND or dyspnea - 2 
orthopnea - 4 
(17) : cough (not otherwise specified) - 1 
cough, nonproductive - 2 
cough, productive - 4 
(18) : gross hemoptysis - 1 
blood-streaked sputum - 2 
foul-smelling sputum - 4 
(19): pleuritic chest pain - 1 
nonpleuritic chest pain - 2 
unknown re pleuritic character - 4 
"tightness", "pressure" or "vague ache" in chest - 5 
(20) : anorexia - 1 
weakness and/or fatigability - 2 
significant malaise - 4 
(21) : night sweats - 1 
chills, fever or sweats - 2 
cyanosis - 4 
(22) : "chronic bronchitis" - 1 
"asthma" - 2 
subjective wheezing - 4 
(23) : "URI" or "cold" - 1 
unresolving "pneumonia" - 2 
"flu" or "grippe" - 4 
(24) : hoarseness - 1 
dysphagia - 2 
(25) : involuntary weight loss 
0: none or unk. (unknown) 
1: <10 lb. 
2: 10-19 lb. 
3: 20 lb. 
4: >20 lb. 
7: amount not indicated 
' 
* 
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SIGNS 
LOCATION 
(26): right side 
0: not applicable (lungs clear or no specified location) 
1: right lung, next digit = lobe 
2: right lung, next digit = field 
3: rales, wheezes or rhonchi - diffuse (next digit = 0) 
4: rales, wheezes or rhonchi - next digit = field 




0: not applicable or unk. 
1: upper 
2: middle 
3: upper and middle 
4: lower 
5: upper and lower 
6: middle and lower 
7: all 3 lobes 
field code 






6: apex and base 
(28): left side 
0: not applicable 
1: left lung, next digit = lobe 
2: left lung, next digit = field 
3: rales, wheezes or rhonchi - diffuse (next digit = 0) 
4: rales, wheezes or rhonchi - next digit = field 
field code 





5: apex and base 
(30) : CLUBBING 
ND (no data) - 0 
(+) - 1 
(-) or (±) - 2 
(31) : accessory muscles - 1 
cyanosis - 2 
(29): lobe code 
0: not applicable or unk. 
1: upper 
2: lower 
3: both lobes 
(32): A-P DIAMETER 
ND or not increased - 0 
tA-P diameter or "barrel-shaped chest" - 1 
"emphysematous chest" - 2 
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(33); LYMPHADENOPATHY 
none or ND - 0 
axillary - 1 
cervical - 2 
supraclavicular - 4 
CHEST X-RAY 
LOCATION OF LESION 
(34): right side 
0: not applicable (no specified location) 
1: right lung, next digit = lobe 
2: right lung, next digit = field 
3: mediastinum only (next digit = 0) 
4: No x-ray done this adm.; data from zero time or since 
8: No x-ray done this adm.; x-ray at or since zero time, 
reading unk. (next five digits = 0) 
9: X-ray not done (next five digits = 0) 
(35): lobe code 
0: not applicable or unk. 
1: upper 
2: middle 
3: upper and middle 
4: lower 
5: upper and lower 
6: middle and lower 
7: all 3 lobes 
field code 




4: hilum or mediastinum 
5: lower * 
6: base 
7: apex and hilum 
(36): left side 
0: not applicable 
1: left lung, next digit = lobe 
2: left lung, next digit = field 
3: mediastinum only 
4: no x-ray done this adm.; data from zero time or since 
(37): lobe code 
0: not applicable or unk. 
1: upper 
2: lingula 
3: upper and lingula 
4: lower 
5: upper and lower 
6: lingula and lower 
7: all lobes 
9: middle lobe (anomalous) 
field code 




4: hilum or mediastinum 
5: lower 
6: base 
7: apex and hilum 
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(38): cavity - 1 
abscess - 2 
empyema - 4 
primary Ghon focus (in cases not diagnosed as tbc.) - 8 
healed or fibrotic apical tbc. (in cases not dxed. as tbc.) - 9 
(39): effusion 




X-RAY EVIDENCE FOR EMPHYSEMA (inapplicable, = 0, in all cases not diagnosed 
as emphysema, unless "emphysema" is stated in x-ray) 
(40): 0: inapplicable (no dx. of emph. or no mention of emph. in x-ray) 
1: X-ray not done. 
2: X-ray negative for "emphysema" (i.e., x-ray diagnosis or 
conclusion thereof). 
3: X-ray positive for "emphysema". 
6: X-ray negative for "emphysema"; bronchogram done. 
7: X-ray positive for "emphysema"; bronchogram done. 
9: "Findings consistent with emphysema" 
or "grossly emphysematous configuration of the lung fields" 
or "probable emphysema" 
(41): bullae - 1 
flattened diaphragms - 2 
tA-P diameter - 4 
(42): fibrosis - 1 
"chronic lung disease" or 
"chronic bronchopulmonary disease" - 2 




none indicated - 0 
old tuberculin - 1 
PPD - 2 
unk. type - 4 
PPD - test strength 
0: not applicable 
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0. T. - test strength 
0: not applicable 







reading (If positive - weakest dilution positive. 
If negative only - strongest dilution negative.) 
0: not applicable 
1: (+) 48 hrs. 
2: (-) 48 hrs. 
3: (±) 48 hrs. 
4: reading not recorded 
5: (+) in past; ND this adm. 
6: (-) in past; ND this adm. 
mode of collection 
not done - 0 
unspecified - 1 
Ad. Hoc. - 2 
24 hour - 4 
mode of concentration 
unspecified - 1 
not concentrated (direct) - 2 
cone. - 4 
mode of collection unspecified; result = atypical AFB - 9 
(Note: 09 implies ND this adm., atypical AFB at zero time) 












not done or ND (no data) 






(+) in past; not done this adm. 
(+) in past; (-) this adm. 
(-) in past; not done this adm. 
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(50): GASTRIC WASHING 
0: not done or ND 
1: inoculated into guinea pig (GP); results (+) 
2: inoculated into GP; results (-) 
3: not specified re GP; results (+) 
4: not specified re GP; results (-) 
5: results? 
6: (+) in past; not done this adm. 
7: (+) zero time or since; (-) this adm. 
9: (-) in past; not done this adm. 
(51): BRONCHIAL SECRETIONS 
0: ND 
1: (+) AFB 
2: (-) AFB 
5: results? 
6: (+) in past; not done this adm. 
7: (-) in past; not done this adm. 
(52): PLEURAL FLUID 
0 ND 
1 (+) AFB 
2 (-) AFB 
5 results ? 
6 (+) in past; 
7 (-) in past; 
(53): URINE 
0 ND 
1 (+) AFB 
2 (-) AFB 
5 results? 
8 (-) in past; 
9 (+) in past; 
(54): STOOL 
0 ND 
1 (+) AFB 
2 (-) AFB 
5 results? 
8 (-) in past; 
9 (+) in past; 
not done this adm. 
not done this adm. 
not done this adm. 
not done this adm. 
not done this adm. 
not done this adm. 
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(55): SWAB FROM LESION OR BIOPSY SPECIMEN 
0: ND 
1: (+) AFB 
2: (-) AFB 
5: results? 
OTHER SKIN TESTS 
(56): HISTOPLASMIN 
0 not done or ND 
1 (+) 48 h rs. 
2 (-) 48 hrs. 
5 results ? 
6 ND; (+) in pas t 
7 ND; (-) in pas t 
(57): COCCIDIOIDIN 
0: not done or ND 
1: (+) 48 hrs. 
2: (-) 48 hrs. 
5: results ? 
6: ND; (+) in past 
7: ND; (-) in past 
1581l BLASTOMYCIN 
0 not done or ND 
1 (+) 48 hrs. 
2 (-) 48 hrs. 
5 results? 
6 ND; (+) in past 
7 ND; (-) in past 
(59): SPUTUM PAP SMEAR 
0: not done or ND 
1: none positive 
2: none positive; at least one equivocal 
3: only one positive 
4: two or more positive 
5: results? 
7: (-) this adm. - (+) in past 
8: ND this adm. - (+) in past 
9: ND this adm. - (-) in past 
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ND or not done - 0 
trachea or carina - 1 
main stem bronchus - 2 
other - 4 
negative - 8 
done, results? - 9 
(61): description 
none or not applicable - 0 
mass - 1 
bleeding or friable - 2 












Test(s) done, none positive. 
Positive biopsy and cytology. 
Positive biopsy; cytology not positive, but done. 
Positive biopsy; cytology not done. 
Biopsy not done; cytology positive. 
Biopsy not positive; cytology positive. 
No tests done or tests unsatisfactory. 
Results unk. 
Biopsy negative; positive at zero time. 
or Biopsy not done; positive at zero time (if 60=0). 
PLEURAL FLUID 
(63) : gross description 
0: none noted or no thoracentesis performed 
1: "yellow", "straw-colored", "amber", "serous" or 




7: Specimen removed but not described. 
(64) : cytology - cell block (pleural fluid) 
0: none positive 
1: none positive; at least one equivocal 
2: only one positive 
3: two or more positive 
7: unk. or not done 










aspiration biopsy - mediastinum - 9 




lung or lobe (or part) - 4 
pericardium 
needle biopsy - lung 
8 
9 
(67)» (68): HISTOLOGY CODE 
10: epidermoid (squamous-cell) carcinoma 
(Use if Ep. Ca. is not further specified.) 
11: highly differentiated; "well differentiated" 
12: mod. diff. or differentiated 
13: slightly differentiated; poorly diff.; mod. undifferentiated 
14: "anaplastic Ep. Ca."; pleomorphic epidermoid Ca. 
15: undifferentiated; dedifferentiated Ep. Ca. 
19: Biopsy not done this adm.; (+) for Ep. Ca. at zero time. 
20: small-cell carcinoma 
21: oval-cell structure ("oat cell Ca.") 
22: polygonal cell structure 
30: adenocarcinoma (mucinous adenocarcinoma) 
31: acinar; scirrhous adeno Ca. 
32: papillary (alveolar cell); bronchiolar Ca. 
33: chiefly "large cells" 
34: "anaplastic adeno Ca. " 
35: "undiff. adeno Ca."; "poorly diff. adeno Ca." 
38: adeno Ca. + bronchiolo-alveolar Ca. 
39: Biopsy not done this adm.; (+) for adeno Ca. at zero time. 
40: large-cell undifferentiated carcinoma 
41: giant-cell anaplastic 
42: pleomorphic 
43: plexiform 
50: combined epidermoid and adenocarcinoma 
51: combined small-cell and adenocarcinoma 
55: "anaplastic Ca."; poorly diff. Ca.; undiff. Ca. 
56: "bronchogenic carcinoma" 
57: "carcinoma" (type unspecified); malignant tumor cells 
(type unspecified) 
59: Biopsy not done this adm.; (+) for undiff. Ca. at zero time. 
, 
' 
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60: bronchial adenoma (type unspecified) 
61: carcinoid type 
62: cylindroid type 
69: Biopsy not done this adm.; cylindroid type (+) at zero time 
70: mesodermal tumor (type unspecified) 
71: fibroma 
72: fibrosarcoma 
76: cancer other than Ca. lung 
77: "metastatic cancer" 
80: tuberculosis 
81: tuberculoma 
82: partial lobectomy in past for tbc.; path. unk. 
90: Biopsy neg. for tbc. 
PULMONARY FUNCTION STUDIES 
(69): not done or ND 
slight resp. impairment (if no categories more than slight) 
moderate resp. impairment (if no categories more than mod.) 
marked resp. impairment (if only one function is» severe) 
severe resp. impairment (if at least two parameters are severe) 
abbreviated study - before thoracic surgery 
(70): expiratory resistance 





7: present but to unknown degree 
THERAPY 
(71): antineoplastic or antituberculous procedures 
surgery to lung - 1 
radiation to lung - 2 
cytotoxic agent - 4 
(72): other therapy 
none indicated - 0 
INH - 1 
PAS - 2 
streptomycin - 4 
(73): DISPOSITION 
none indicated or "home" - 0 
PMD - 1 
return to clinic - 2 
sanatorium - 4 
Pt. died - 9 
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(74): AUTOPSY 
0: inapplicable - Pt. alive at discharge. 
1: Pt. died. Autopsy revealed no evidence of T.E.C. 
2: Pt. died. Autopsy: tuberculosis. 
3: Pt. died. Autopsy: Ca. lung. 
4: Pt. died. Autopsy: emphysema. 
5: Autopsy: tbc. + Ca. lung 
6: Autopsy: tbc. + emphysema 
7: Autopsy: Ca. lung + emphysema 
9: Pt. died - no autopsy or autopsy findings unk. 
(75): If diagnosis is Ca. lung: 
inapplicable - 0 
primary Ca. - 1 
secondary Ca. - primary known - 2 
secondary Ca. - primary unk. - 4 
secondary Ca. - primary uncertain but there is 
diagnosed primary Ca. elsewhere - 7 
"probably primary" - 9 
(80): SPECIAL COMMENTS 
0: negative cytology - bronchoscopy report: "changes characteristic 
of chronic emphysema" (Dx. apparently established with 1A-P 
diameter, bronchoscopy report, (+) smoking history, x-ray - 
no mention of emphysema) 
1: CSF (+) for AFB 
2: "lung puncture" - cytology negative 
3: thoracoscopy - negative 
4: intratracheal lipiodal with bronchography 
diagnosis: "peripheral primary Ca. RUL" 
5: diagnosis = senile emphysema 
6: CSF (-) for AFB 
7: craniotomy done; biopsy: metastatic Ep. Ca. 
8: needle biopsy, ileum or ischium: metastatic undiff. Ca. 
9: pulmonary function studies - ND this adm. ; results in 69_, 70_ 
from previous adm. 
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